Sonoma Pharmaceuticals Inc (SNOA) — Capital Reinvestment Ratio
Latest as of March 2025:
0.00x
Sonoma Pharmaceuticals Inc (SNOA) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($565.00K) in capital expenditures ($2.00K). See SNOA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$565.00K
USD
Capital Expenditures
$2.00K
USD
Data as of
Mar 2025
Most recent filing
Sonoma Pharmaceuticals Inc Capital Reinvestment Ratio (2013–2013)
This chart tracks Sonoma Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc (2013–2013)
Year-by-year Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc from 2013 to 2013. For live market cap and broader valuation context, see Sonoma Pharmaceuticals Inc (SNOA) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.22x | $1.15 Million | $257.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow